Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
46.10 GBX | -0.86% | +0.33% | +13.83% |
09-30 | EARNINGS: Alliance Pharma swings to profit; DG Innovate loss widens | AN |
09-30 | Alliance Pharma plc Provides Revenue Guidance for the Full Year 2024 | CI |
Yield (Y) | Yield (Y+1) | P/E ratio | Price to Book | EV / Sales | EV / EBITDA | EV / EBIT | Capi. ($) | ||
---|---|---|---|---|---|---|---|---|---|
+0.57% | +0.60% | 16.02x | 1.086 | 1.71x | 7.47x | 8.02x | 318M | ||
+0.78% | +0.86% | 37.74x | 5.982 | 7.73x | 27.56x | 33.38x | 51.13B | ||
+1.38% | +1.46% | 19.56x | 1.850 | 1.9x | 9.21x | 14.09x | 31.65B | ||
+1.42% | +1.85% | 28.96x | 2.077 | 2.17x | 11.15x | 12.77x | 19.18B | ||
+0.74% | +0.80% | 25.64x | 3.939 | 4.07x | 16.25x | 19.46x | 14.09B | ||
+0.60% | +0.64% | 22.54x | 4.215 | 4.3x | 14.55x | 16.62x | 11.82B | ||
+4.61% | +4.62% | 13.05x | 0.9946 | 1.81x | 7.96x | 9.75x | 5.44B | ||
+0.60% | +1.26% | 58.94x | 4.494 | 9.04x | 34.36x | 52.69x | 5.11B | ||
+0.19% | +0.21% | 29.8x | 4.745 | 3.08x | 16.66x | 20.53x | 5.09B | ||
+4.40% | +5.67% | 8.44x | 1.538 | 2.12x | 5.82x | 6.99x | 4.98B | ||
+5.60% | +5.69% | 12.21x | 1.907 | 1.94x | 7.15x | 8.97x | 4.44B | ||
+0.79% | +0.79% | 37.8x | 8.656 | 7.4x | 25.92x | 28.48x | 4.22B | ||
+2.29% | +2.73% | 11.73x | 0.8366 | 2x | 7.6x | 9.37x | 4.17B | ||
+1.89% | +2.01% | - | - | 4.53x | 16.94x | 21.39x | 3.71B | ||
+2.19% | +2.29% | 27.43x | 6.806 | 7.74x | 23.31x | 25.1x | 2.85B | ||
+0.19% | +0.19% | 20.4x | 3.038 | 2.25x | 10.28x | 14.19x | 2.34B | ||
+1.92% | +2.31% | 18.39x | 2.184 | 2.11x | 10.45x | 13.5x | 2.26B | ||
Average | +1.77% | +2.00% | 24.29x | 3.4 | 3.88x | 14.86x | 18.55x | 10.17B | |
Weighted average by Cap. | +1.36% | +1.54% | 27.99x | 3.84 | 4.54x | 17.36x | 21.68x |
- Stock Market
- Equities
- APH Stock
- Sector Alliance Pharma plc
- Sector dividends
MarketScreener is also available in this country: United States.
Switch edition